Search
Moderna CEO expects emergency use nod for COVID-19 vaccine after FDA panel meet
- Moderna's Covid-19 vaccine could be approved for emergency use within 24 to 72 hours after the US health regulator’s advisory committee meeting.
- The Food and Drug Administration is scheduled to hold the meeting on Dec 17 to discuss the company’s request for emergency use authorisation for its vaccine.
- Moderna currently has millions of doses of vaccines that can be shipped as soon as its request is granted.